Wu Xiaobin's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Mar 18, 2025
- Accession no.
- 0001651308-25-000051
- Filed
- Mar 18, 2025
- Trade date
- Mar 14, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wu XiaobinCIK 0001739452 | Officer (President, COO & GM China) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | RMB Shares | SSaleDisposed | 0 | $0.00F5 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
The Reporting Person disposed of a portion of his economic interest in the RMB Shares Employee Participation Plan and expects to receive net proceeds of approximately RMB7,657,022 (or US$1,057,600 based on an exchange rate of US$1.00 = RMB7.24) for such disposal.
Referenced by the price of 1 transaction in Table I.